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Abstract 
Purpose: Although overall paediatric septic shock mortality is decreasing, refractory septic shock (RSS) is still associ-
ated with high mortality. A definition for RSS is urgently needed to facilitate earlier identification and treatment. We 
aim to establish a European society of paediatric and neonatal intensive care (ESPNIC) experts’ definition of paediatric 
RSS.
Methods: We conducted a two-round Delphi study followed by an observational multicentre retrospective study. 
One hundred and fourteen paediatric intensivists answered a clinical case-based, two-round Delphi survey, identify-
ing clinical items consistent with RSS. Multivariate analysis of these items in a development single-centre cohort (70 
patients, 30 % mortality) facilitated development of RSS definitions based on either a bedside or computed severity 
score. Both scores were subsequently tested in a validation cohort (six centres, 424 patients, 11.6 % mortality).
Results: From the Delphi process, the draft definition included evidence of myocardial dysfunction and high blood 
lactate levels despite high vasopressor treatment. When assessed in the development population, each item was 
independently associated with the need for extracorporeal life support (ECLS) or death. Resultant bedside and com-
puted septic shock scores had high discriminative power against the need for ECLS or death, with areas under the 
receiver operating characteristics curve of 0.920 (95 % CI 0.89–0.94), and 0.956 (95 % CI 0.93–0.97), respectively. RSS 
defined by a bedside score equal to or higher than 2 and a computed score equal to or higher than 3.5 was associ-
ated with a significant increase in mortality.
Conclusions: This ESPNIC definition of RSS accurately identifies children with the most severe form of septic shock.
Keywords: Shock, Septic, Paediatrics, Acidosis, Lactic, Resuscitation, Failure, Cardiac
*Correspondence:  pierre.tissieres@aphp.fr 
1 Paediatric Intensive Care Unit, Paris South University Hospitals, AP-HP, 78 
Rue du General Leclerc, 94275 Le Kremlin-Bicêtre, France
Full author information is available at the end of the article
Take-home message: The absence of a reliable definition for 
refractory septic shock in children represents a barrier to planning 
and interpretation of clinical trials of the use of specific and targeted 
therapeutics. The ESPNIC definition comprising lactic acidosis, 
vaso-inotrope dependency and septic cardiomyopathy is a highly 
discriminating definition and was validated on a large multicenter 
international cohort of patients in septic shock.
1949
Introduction
Infection remains the leading cause of paediatric mor-
tality worldwide [1]. In most high-income countries, 
access to care, vaccination campaigns and improvement 
in intensive care have drastically decreased deaths from 
infection. Similar to adults, recent paediatric studies have 
shown an increase in the incidence of invasive infection 
and septic shock and a relative decrease in mortality 
[2–4].
Recently, sepsis and septic shock definitions in adults 
were revised [4–7]. The aim of the Sepsis-3 definition 
was to help the clinician in the detection of septic shock 
patients and to treat them according to their risk of death. 
The sepsis-related organ failure assessment (SOFA) [8] 
has a prominent place in this definition, but is neither 
adapted nor validated in paediatric patients. The clinical 
course of septic shock is affected by the age and immune 
state of the patient, the virulence of the pathogen, and the 
haemodynamic adaptation to circulatory failure. Paedi-
atric logistic organ dysfunction (PELOD) is a paediatric 
organ dysfunction score validated in the severity classifi-
cation of patients with sepsis [9]. However, similar to the 
SOFA score, it does not impact patient management at 
the bedside.
The Surviving Sepsis Campaign [10] and the American 
College of Critical Care Medicine (ACCM) guidelines 
for hemodynamic support in neonates and children [11] 
remain the most recognized standards of care. Specific 
therapies such as activated protein C [12, 13] or early 
goal-directed therapy [14, 15] have not been associated 
with a consistent decrease in mortality. The term sep-
tic shock encompasses various aetiologies and immune 
states for which specific interventions may have vari-
able results [16]. However, the subset of patients who are 
unresponsive to standard resuscitation are often labelled 
as having ‘refractory septic shock’ (RSS). RSS is typified 
by circulatory failure due to septic cardiomyopathy [17–
19] with or without vasoplegia [19]. Importantly, effective 
short-term support of the circulation with newer vaso-
active agents or extracorporeal life support (ECLS) [20] 
means that RSS is potentially reversible [21, 22]. To max-
imise the impact of these rescue therapies, a robust tool 
for early identification of RSS is required,
The Infection, Systemic Inflammation and Sepsis sec-
tion of the European Society of Paediatric and Neona-
tal Intensive Care (ESPNIC) designated a taskforce to 
define paediatric RSS [23]. We performed a study linking 
a two-round Delphi survey with the development of sep-
tic shock scores. These scores aimed at an early indenti-
fication of RSS patients with a high risk of mortality at 
any moment during clinical care. The scores were sub-




The first part of the Delphi study was a clinical case-
based questionnaire. Two members (L.M. and P.T.) of 
the Infection, Systemic Inflammation and Sepsis section 
of ESPNIC were assigned to create four clinical cases of 
septic shock patients with varying levels of shock and 
organ dysfunction.
The characteristics of the clinical cases were set follow-
ing a review of the literature on septic shock and a case 
analysis of septic shock patients, and covered the whole 
clinical spectrum of disease severity. Five members from 
the taskforce (G.M., S.N., M.P., M.K., N.J.G.J.) reviewed 
the cases for consistency and objectivity. All clinical 
cases were composed of vignettes with specific clinical 
and biological parameters (later described as criteria and 
corresponding cut-offs), encompassing the evolution of 
sepsis. For each vignette, responders were asked to grade 
the occurrence of RSS (0 = no RSS to 10 = yes) (see sup-
plementary file 1). The questionnaire was then sent to all 
ESPNIC members via an Internet survey supplier (Sur-
veyMonkey Inc., Palo Alto, CA, USA).
Criteria extracted from the clinical vignettes were 
ranged according to the distribution of their strength of 
association with RSS. Criteria graded A (first quartile) 
and B (second quartile) were selected and compiled in 
four draft definitions constituted by a minimal definition 
alone or with up to three additional organ failures. Pre-
liminary definitions were then tested in the second part 
of the Delphi study. Participants of this second part had 
access to the results of the first study. They were asked 
to choose one of the four definitions and to re-score 
the definition cut-off values issued from the first part’s 
results. Based on this second round, criteria graded A or 
B were incorporated into the selected RSS draft defini-
tion. (See supplementary file 2 for additional information 
on methodology).
Development population application and definition 
adjustment
The RSS draft definition was first tested in a development 
population. All patients less than 18  years old admitted 
to the Paediatric Intensive Care Unit (PICU) at Centre A 
for septic shock, according to consensus definition [24], 
and requiring vasopressor or inotrope therapy between 
January 1, 2010 and December 31, 2013 were analysed. 
Exclusion criteria were: (1) the presence of limitations of 
life support at septic shock onset; (2) postmenstrual cor-
rected age <37 weeks; and (3) perinatal sepsis defined as 
sepsis occurring in the first 7 days of life.
Protocols for clinical care of septic shock patients did 
not change during the 3-year study period. Patients were 
retrospectively identified using hospital records and data 
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collected. The French Intensive Care Society ethics com-
mittee approved this study (CE SRLF 14-38). Clinical 
variables included in the definition or used to describe 
the populations or outcomes, and occurring before the 
occurrence of the composite endpoint PICU mortal-
ity and/or ECLS, were recorded (see supplementary file 
2). Draft definition criteria identified in the Delphi study 
were evaluated against two outcomes: PICU mortal-
ity, and the composite endpoint PICU mortality and/or 
ECLS. Multivariable Cox regression was performed to 
study the association between the variables used in the 
definition and these two outcomes, to define two RSS 
scores. An easy to calculate score was named “bedside 
RSS score” and a more complex one was named “com-
puted RSS score”.
RSS definition assessment in a validation population
Both bedside and computed RSS scores were tested to 
evaluate their association with mortality and the com-
posite endpoint mortality/need for ECLS. This was 
done on a validation population consisting of a cohort 
of PICU-admitted patients, retrospectively enrolled in 6 
PICUs in four countries (Australia, France, Netherlands 
and United Kingdom; Table  1). Inclusion and exclusion 
criteria were identical in the development and validation 
population. Data were collected retrospectively (C.W., 
E.J., L.J.S., L.M., M.K., M.P., N.J.G.J., S.N., S.R., S.R.). L.M. 
independently reviewed the consistency of the collected 
data. All six centres obtained local ethical approval for 
the retrospective analysis of the patient data and waiver 
of informed consent from legal representatives.
Statistical analysis
Continuous variables were tested for normality with Kol-
mogorov–Smirnov test and compared with Student’s t 
test or Mann–Whitney test, as appropriate. Non-con-
tinuous variables were tested with Chi-squared test or 
Fisher’s exact test, as appropriate. Data were described as 
frequencies and percentages, means and standard devia-
tions or median and interquartile range, as appropriate. 
Multivariable Cox’s regression with backward-stepwise 
method was performed having as outcomes mortality or 
the composite endpoint mortality/need for ECLS. Covari-
ates inserted in the models were the variables identified 
through the Delphi process and the patients’ age [3]. 
Adjusted hazard ratios were used to weight covariates 
and included in the scores. The model goodness of fit was 
evaluated with Omnibus test. Receiver operating char-
acteristics (ROC) analysis was then performed with the 
validation population for both scores and areas under the 
curves (AUC) were calculated to assess for the discrimi-
native power of these scores. The best thresholds for these 
scores were obtained with the calculation of sensitivity, 
specificity, positive and negative predictive values and the 
Youden’s index (sensitivity + specificity – 1). The DeLong 
test was used to compare the AUC of both scores [25]. 
Survival of RSS patients according to both scores have 
been evaluated by Kaplan–Meier curves and these latter 
have been tested using Logrank test. A p value of less than 
0.05 was considered statistically significant. Statistical 
analyses were performed with SPSS for Macintosh, v.22.0 
(SPSS, Chicago, IL, USA) and GraphPad Prism®, v. 5.0a 
(GraphPad Software, La Jolla, CA, USA) softwares.
Results
Draft of the definition
From April 9 to July 2 2014, 114/170 (67  %) physicians 
members of the ESPNIC representing 27 countries and 
75 PICUs answered the first round of the Delphi study. 
The physicians PICU experience was less than 10  years 
for 35.6 %, 10–20 years for 44.1 % and more than 20 years 
for 20.3  %. Results from this first round are presented 
in Table  2. Items graded A (first quartile of associa-
tion with diagnosis of RSS) or B (second quartile) were 
selected for the second round. They were condensed into 
a minimal definition (lactic acidosis with vaso-inotrope 
Table 1 Hospitals and patients
PICU paediatric intensive care unit, M Medical, S Surgical, ECLS Extra-Corporeal Life Support, C Cardiac
Hospitals Type of PICU PICU admissions and mortality Number of septic shock cases and mortality Weight in the cohort (cases/deaths)
Development population
 Centre A M, S, ECLS 3109 (4.2 %) 70 (30 %) 100 %/100 %
Validation population
 Centre B M, S, ECLS 4608 (3.4 %) 40 (7.5 %) 9.4 %/6.1 %
 Centre C M, S 3875 (7.1 %) 165 (13.9 %) 38.9 %/46.9 %
 Centre D M 1288 (5.6 %) 101 (6.9 %) 23.8 %/14.3 %
 Centre E M, S, C 3145 (2.7 %) 18 (33.3 %) 4.2 %/12.2 %
 Centre F M, S, C, ECLS 3117 (4.7 %) 57 (3.5 %) 13.4 %/4.1 %
 Centre G M, S 3150 (1.9 %) 44 (18.2 %) 10.4 %/16.3 %
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dependency and myocardial dysfunction) with addi-
tional organ failures graded A or B [hepatic insufficiency, 
severe acute respiratory distress syndrome (ARDS) with 
the Berlin definition [26] or failure to achieve effective 
continuous renal replacement therapy (CRRT)]. The 
vaso-inotrope dependency was assessed with the use of 
the vaso-inotrope score [VIS =  (epinephrine +  norepi-
nephrine in mcg/kg min) × 100 + (dobutamine + dopa-
mine in mcg/kg  min)  +  (vasopressin in mcg/
kg  min)  ×  10,000  +  (milrinone in mcg/kg  min)  ×  20] 
[27]. In the second round of the Delphi study, from Sep-
tember 23 to November 21 2014, 61 physicians answered 
Table 2 Results of the first round of the Delphi study: association of clinical criteria with refractory septic shock diagnosis
Criteria and cut-offs Scoresb Number of iteration Gradec
Blood lactates
 >4 mmol/L 8 (7–9.5) 11 C
 >6 mmol/L 9 (8–10) 9 B
 >8 mmol/L 9.5 (9–10) 6 A
 >10 mmol/L 9.5 (9–10) 4 A
 Stablea 9 (8.5–9.5) 2 B
 Increasea 8 (6.5–8.8) 3 B
ScvO2 < 70 % 8 (6.5–8.8) 6 C
Vaso-inotrope score (mcg/kg min)
 >50 8 (6–8) 11 C
 >100 8 (7.5–8.5) 8 C
 >125 8 (8–9) 7 C
 >150 8 (8–9.5) 6 C
 >175 9 (8–10) 4 B
 >200 9 (8.5–9.5) 2 B
Vaso-inotrope association bitherapy 8 (8–8.5) 6 C
Vaso-inotrope association tritherapy 9 (8.5–9.5) 2 B
ARDS
 Mild (P/F 200–299) 8 (6.8–8.5) 8 C
 Moderate (P/F 100–199) 8 (7.3–9.5) 6 C
 Severe (P/F < 100) 8.5 (7.8–9.3) 2 B
Arterial hypotension 8 (8–9.8) 10 C
Cardiac index (L/min m2)
 <6 8 (6–9) 13 C
 <4.5 8 (6–9.3) 12 C
 <3.3 8 (8–9.8) 10 C
 <2.2 10 (9–10) 3 A
Cardio circulatory arrest 10 (10–10) 1 A
Left ventricle ejection fraction (%)
 <45 8 (5.3–8.3) 12 C
 <35 8 (8–9.2) 8 C
 <25 9.5 (9.3–9.8) 2 A
Cardiac arrest
 Prior PICU admission 9 (9–9) 1 B
 In PICU 10 (10–10) 1 A
Hepatic insufficiency (prothrombin time/factor V <50 % or INRe >2) 10 (10–10) 1 A
Need for CRRT 6 (6–8) 5 D
CRRT dysfunction 10 (10) 1 A
Procalcitonin at admission (ng/mL)
 >50 8 (4.5–9) 3 D
 >200 6 (4.5–8) 3 D
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the survey and 37 (60.6 %) selected the minimal definition 
without additional organ failure. They validated six items 
determined in the first round as important with a grade A 
or B for the diagnosis of RSS. The draft definition for RSS 
was the association of: (1) blood lactate >8 mmol/L or a 
1  mmol/L lactate increase after 6  h of resuscitation, (2) 
vaso-inotrope dependency (VIS >200  mcg/kg  min), and 
(3) myocardial dysfunction, defined as the occurrence of 
a resuscitation-responsive cardiac arrest in PICU or car-
diac ultrasound findings with left ventricle ejection frac-
tion (LVEF) <25 % or a cardiac index <2.2 L/min m2.
Development population application and definition 
adjustment
During a 4-year period between January 1, 2010 and 
December 31, 2013, 78 patients were admitted at the 
Centre A PICU for septic shock requiring inotropes or 
vasopressors. Eight were excluded because of limita-
tions of life support on admission. Of the remaining 70 
patients, 21 (30  %) died during PICU stay, of whom 11 
(15.7 %) were classified in RSS by the draft definition with 
a mortality rate of 100 % (sensitivity = 52.4 %, specific-
ity  =  100  %) and a median delay from shock onset to 
death of 19 (12–72)  h. No comorbidity was found in 
47.1  % of the patients while 22 patients (31.4  %) were 
immunocompromised.
In the multivariable analysis, the model goodness of 
fit was satisfying for each step (p = 0.577 and p = 0.717 
at the first and second steps, respectively). Data from 
the last step were selected and used to create septic 
shock scores. Mortality or the need for ECLS was inde-
pendently associated with the worst VIS [HR  =  1.001 
(95 % CI: 1.0009–1.0011) p = 0.01], worst arterial lactate 
[HR = 1.1 (95 % CI: 1.01–1.23), p = 0.032] and presence 
of myocardial dysfunction [HR = 18, (95 % CI: 3.4–95.4), 
p = 0.001]. Lactates and VIS (ρ = 0.34; p = 0.008) as well 
as LVEF and lactates (ρ  =  –0.67; p  <  0.001) were cor-
related. Age was not significantly associated with the 
outcome [HR  =  0.99, (95  % CI: 0.98–1.01), p  =  0.50]. 
Following this, two septic shock scores (SSS) were 
constituted:
 – Computed SSS calculated as follows, (cSSS) = 1.001VIS 
in mcg/kg min + 1.1arterial lactate in mmol/L + 18 (in the pres-
ence of myocardial dysfunction).
  – Bedside SSS (bSSS) based on 5 points with coefficient 
ranked and rounded to have a user-friendly score:
  – VIS > 200 mcg/kg min = 1 point
  – Arterial lactate >8 mmol/L or its increase of 1 mmol/L 
after 6 h of care = 1 point
  – Myocardial dysfunction as defined above = 3 points.
Validation population
The validation population consisted of 456 patients 
admitted for septic shock requiring inotropes or vaso-
pressors, with a mortality rate of 17.8 % (Fig. 1). Thirty-
two of these patients had limitations of life support on 
admission and were excluded from analysis. The mor-
tality for the remaining 424 patients was 11.6  %. The 
main characteristics of both development and validation 
populations are compared in Table  3. The two studied 
populations differed significantly in terms of prognostic 
factors and outcomes. The paediatric index of mortality 
score (PIM2) [17 (11–21) vs. 7.6 (3–15), p < 0.001], peak 
blood lactates [4.7 (2.3–7.8) vs. 2.6 (1.6–5.2), p  <  0.01] 
and mortality (30 vs. 11.6 %, p < 0.001) were significantly 
higher in the development cohort. No comorbidity was 
found in 52 % of the patients while 60 patients (16.3 %) 
were immunocompromised. The origin of infection was 
nosocomial in 27.6 % and community-acquired in 72.4 % 
of the patients in the validation cohort. A microbiologi-
cal diagnosis was positive for 317 patients (74.8 %; bacte-
rial in 83.9 %, viral in 12.9 %, fungal in 2.5 % and parasitic 
in 0.6  %). The most prevalent pathogens were Neisseria 
meningitidis in 70 patients (22.4 %), Group-A Streptococ-
cus in 38 patients (12 %), Streptococcus pneumoniae in 16 
Table 2 continued
Criteria and cut-offs Scoresb Number of iteration Gradec
Time since PICU admission (h)
 >6 8 (4.5–9) 7 C
 >24 6 (4.5–8) 3 D
Scores are expressed as medians and interquartile
ScvO2 central venous saturation of oxygen, ARDS acute respiratory distress syndrome graded with the Berlin definition, PICU paediatric intensive care unit, INR 
international normalized ratio, CRRT continuous renal replacement therapy
a Blood lactates: stable defined as less than 1 mmol/L change between two consecutive samples, increase defined as more than 1 mmol/L increase between two 
samples
b Scores represents the association of each criteria with the clinical diagnosis of RSS (0 = no RSS to 10 = RSS)
c Each criteria was graded from A (first quartile—most associated with diagnosis of refractory septic shock) to D (fourth quartile—least associated with diagnosis of 
refractory septic shock)
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patients (5  %) and Staphylococcus aureus in 29 patients 
(9.1 %). The pathogen was a Gram-negative bacillus in 73 
patients (23 %), including E. coli for 34 patients (10.7 %). 
Patients intubated for septic shock reached 87  %, and 
severe ARDS was present in 27.8 % of all patients.
Both scores were calculated for all patients and per-
formance analysed with ROC curves (Fig.  2). The dis-
criminative power for association with mortality or 
need for ECLS was calculated for computed and bed-
side scores, with AUC = 0.956 (95 % CI: 0.93–0.97) and 
0.920 (95  % CI: 0.89–0.94), respectively. The computed 
score had a higher AUC as compared to the bedside score 
(p = 0.0092). The performances of both scores for associ-
ation with death or use of ECLS are presented in Table 4. 
The bedside SSS with a cut-off at 2 was associated with 
a positive predictive value of 60.3  % and a negative pre-
dictive value of 97.8  % (positive likelihood ratio =  11.6, 
Youden’s index =  0.765). The computed SSS with a cut-
off at 3.5 was associated with a positive predictive value 
of 55 % and a negative predictive value of 98.5 % (positive 
likelihood ratio = 9.4, Youden’s index = 0.802). Mortality 
rate were compared for RSS populations defined by the 
bedside and the computed scores, with, respectively, 41 
deaths among 68 RSS patients (mortality 60.3 %) versus 8 
deaths among 356 non-RSS patients (mortality 2.2 %) for 
the bedside score and 44 deaths among 80 RSS patients 
(mortality 55  %) versus 5 deaths among 344 non-RSS 
patients (mortality 1.5 %). Survival curves for each score 
are presented in Fig. 3 and mortality is significantly higher 
in RSS patients for both scores (p < 0.001 and p < 0.001).
Discussion
The septic shock scores (bedside and computed) are the 
first scores that aim at diagnosing refractory septic shock 
in paediatric patients admitted in PICU for septic shock. 
The scores were effective to identify the most severely 
ill patients. A bedside score ≥2 or computed score ≥3.5 
defined RSS with a mortality higher than 55 %. Although 
statistically different, the diagnostic accuracy of both 
scores seems clinically equivalent with an absolute dif-
ference of 0.035 in the AUC. The clinical utility for each 
score is different. The bSSS is a bedside tool potentially 
useful for stratifying the severity and assessing the immi-
nent risk of death, helping clinicians to implement rescue 
therapies. Its simplicity to use may counter-balance the 
small loss in accuracy. The cSSS is a potentially powerful 
and discriminating epidemiological tool and its calcula-
tion needs a computer or a smartphone application.
Defining a study population has implications on tri-
als outcomes and may explain contradictory outcomes 
from historical large-scale randomized trials [12, 13, 
28]. Recently, the sepsis-3 adult definition has refined 
the identification of septic shock patients [7]. How-
ever, although focusing exclusively on adults, the main 
advance of the sepsis-3 definition is the stratification of 
patients into two categories: sepsis and septic shock. In 
adults, the SOFA score assesses organ failures after sepsis 
with good correlation to mortality [8]. This adult score is 
not adapted for paediatric patients. The paediatric index 
of mortality (PIM2) [29] and the PELOD-2 [30] score are 
paediatric scores that can be used to compare population 
of patients but are not specific for sepsis. In our study, the 
two scores were built with arterial lactate, vaso-inotrope 
score and septic cardiomyopathy and were associated 
with poor outcome. Each of those criteria was indepen-
dently associated with mortality or the need for ECLS. 
Blood lactate is a widely used biomarker in septic shock 
patients. The highest value during the first 24 h of PICU 
was associated with mortality in paediatric septic shock 
patients [31]. Dynamic values, such as lactime [32] or lac-
tate clearance [33], are better predictors of mortality in 
adult patients, but they are not used routinely. Interest-
ingly, the best predictor of survival to ECLS therapy in 
children with septic shock was a low pre-ECLS arterial 
lactate value [22].




Admitted for septic shock  
n=456 (2,3%)  
(mortality 16.9%) 
Diagnosed in refractory 
septic shock with bSSS ≥2 
n=68 (16%) 
Dead or in ECLS 
n=41  
(mortality 60.3%) 
Alive at PICU discharge 
n=27 
Diagnosed as non refractory 
septic shock with bSSS <2 
n=356 (84%) 
Dead or in ECLS 
n=8  
(mortality 2.2%) 
Alive at PICU discharge 
n=348 
Excluded due to 
limitations of life support 
n=32  
(mortality 100%) 
Fig. 1 Flow chart of the validation cohort
1954
Use of vasopressors or inotropes to treat fluid-unre-
sponsive shock is still the first line of treatment [10, 11]. 
The VIS is a score used to assess the responsiveness and 
dependency to vasopressor in cardiac ICUs [27], with 
a VIS >200 being associated with mortality or need for 
ECLS in post-operative paediatric cardiac patients with 
low cardiac output syndrome [34]. In our study, norepi-
nephrine was used in 77.2 % of the patients and an ino-
trope (dobutamine, dopamine, epinephrine or milrinone) 
added in 80.2 %. The cut-off chosen in the definition by 
the two-round survey is higher than the VIS scores found 
in the literature in patients under ECLS therapy for other 
indications [22, 35, 36] or alternative vasopressors [37], 
but similar to calculated inotrope scores in adult patients 
needing ECLS support for septic shock [21].
The presence of a septic cardiomyopathy was indepen-
dently associated with increased mortality or need for 
ECLS in the development population [OR  =  18, (95  % 
CI: 3.4–95.4)]. Septic cardiomyopathy is the component 
carrying the highest weight in the septic shock scores. 
Although the pathogenesis of septic cardiomyopathy is 
multifactorial, it is known to be reversible [36, 37, 38]. 
LVEF has proven to be sufficient for the diagnosis of low 
cardiac output with a LVEF <40  % [39]. Diastolic dys-
function and right ventricle dysfunction in sepsis are less 
studied but their role in septic cardiomyopathy seems to 
precede systolic left ventricular dysfunction [39]. Cardiac 
arrest is the ultimate evolution of septic shock. In our 
study, in both cohorts, 59.7  % of the deceased patients 
had a resuscitated cardiac arrest in the course of the sep-
tic shock. Patients in cardiac arrest due to septic shock 
can benefit from ECLS therapy with an overall survival of 
75 % in one series [22], compared to 32.7 % in our cohort. 
Improved assessment of septic cardiomyopathy before 
cardiac arrest occurs is mandatory. Regular evaluation of 
cardiac output and function can be based on invasive and 
non-invasive criteria. Non-invasive quantification relies 
mostly on continuous oesophageal or supra-sternal Dop-
pler or cardiac ultrasound. Importantly, it is well recog-
nized that children with septic shock without apparent 
need for inotropes can subsequently develop septic car-
diomyopathy and low cardiac output [19]. This haemo-
dynamic pattern can be explained by the unmasking of 
septic cardiomyopathy by restoration of vasomotor tone 
in resuscitated shock after norepinephrine infusions, as 
well as over-enthusiastic fluid resuscitation [17].
This study has some limitations. First, the data collec-
tion was retrospective and thus is at risk of missing data 
and information bias. Second, data were collected dur-
ing the whole septic shock care period with selection of a 
unique worst value for each item. Thus, the maximal val-
ues could be at varying time points in the clinical course. 
Calculation of the score was based on worst values for 
each criterion that may not be synchronous. This could 
Table 3 Patient characteristics in the development and validation populations
All characteristics are during PICU stay. Continuous data are expressed as medians (interquartile). Categorial data are expressed as number (percent)
PIM2 paediatric index of mortality 2, ARDS acute respiratory distress syndrome graded with the Berlin definition, CRRT continuous renal replacement therapy, ScvO2 
central venous saturation of oxygen, ECLS extra-corporeal life support, PICU paediatric intensive care unit
a Blood lactates: stable defined as less than 1 mmol/L change between two consecutive samples, increase defined as more than 1 mmol/L increase between two 
samples
Development population (n = 70) Validation population (n = 424) p value
Age (months) 28 (8–76) 32 (10–87.8) 0.60
Sex ratio M/F 1.92 1.27 0.16
PIM2 score 17 (11–21) 7.6 (3–15) <0.001
Nosocomial infection 25 (35.7 %) 117 (27.6 %) 0.21
Absence of comorbidity 33 (47.1 %) 220 (52 %) 0.53
Immunocompromised patients 22 (31.4 %) 69 (16.3 %) <0.001
Use of mechanical ventilation 54 (77.1 %) 369 (87 %) 0.04
Severe ARDS 14 (20 %) 118 (27.8 %) 0.22
Cardiac arrest 14 (20 %) 48 (11.3 %) 0.06
Use of CRRT 11 (15.7 %) 47 (11.1 %) 0.36
Maximal blood lactates (mmol/L) 4.7 (2.3–7.8) 2.6 (1.6–5.2) <0.01
Lactate increasea 25 (35.7 %) 100 (23.6 %) 0.06
ScvO2 <70 % 25 (35.7 %) 141 (33.2 %) 0.84
Use of ECLS 2 (2.9 %) 2 (0.6 %) 0.15
PICU mortality 21 (30.0 %) 49 (11.6 %) <0.01
Number of days in PICU 6 (2–11) 4 (1.4–8.3) 0.02
Delay from septic shock onset to death (days) 2 (0.6–4.5) 1 (0.5–4) 0.61
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have increased the estimated risk of death for patients 
in the validation population as well as overestimating 
the AUCROC. However, most patients died shortly after 
admission (median time to death = 1 day) and the high-
est values were mostly collected within the first 24 h after 
admission. Similarly, a delay to death of less than 24  h 
was also shown in more than 13,000 paediatric sepsis 
admissions in the North Thames, UK, region [40]. Other 
scores used similar methodology during their creation, 
including SOFA and PELOD [8, 30]. Evaluating the kinet-
ics of both scores as well as its composing criteria in the 
course of the disease is important and needs prospective 
evaluation. Third, there were significant baseline differ-
ences in the characteristics of the two populations (devel-
opment and validation) and between centres included 
in the validation cohort. These may be explained by dif-
ferences in patients’ recruitment and severity. Some of 
them were known prognostic factors in septic shock such 
as PIM2 scores and immunosuppression or were part 
of either the definition (blood lactates) or the outcome 
(mortality), outlining the patients’ recruitment and sever-
ity difference between both cohorts. The high mortality 
Fig. 2 Receiver operating characteristics curves for the computed 
septic shock score (cSSS) and the bedside septic shock score 
(bSSS). Area under the ROC curve in the validation population was 
0.956 (95 % CI = 0.93–0.97, p < 0.01) for the cSSS and 0.920 (95 % 
CI = 0.89–0.94, p < 0.01) for the bSSS
Table 4 Predictive performance of septic shock scores and their best threshold values
Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) Likelihood ratio
Bedside septic shock score (bSSS)
 ≥1 91.8 78.9 36.3 98.7 4.4
 ≥2 83.7 92.8 60.3 97.8 11.6
 ≥3 63.3 95.2 63.3 95.2 13.2
 ≥4 59.2 98.1 80.6 94.8 31.7
Computed septic shock score (cSSS)
 ≥2.5 98 71.7 31.2 99.6 3.5
 ≥3.5 89.8 90.4 55 98.5 9.4
 ≥5.0 81.6 94.7 66.7 97.5 15.3
 ≥21 57.1 98.7 84.8 94.6 42.9
a 
b 
RSS (bSSS ≥ 2/5) 
No RSS (bSSS < 2/5) 
RSS (cSSS ≥ 3,5) 
No RSS (cSSS < 3,5) 
20 30 40 0 10 





















Fig. 3 Survival curve of refractory septic shock defined by a a bed-
side septic shock score ≥2.5, and b a computed septic shock score 
≥3.5
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rate in the development cohort ensured the high power 
of this study to select the criteria associated with refrac-
tory septic shock. Meanwhile, the scores have an excel-
lent discriminative value in the validation cohort. This 
reinforces the quality of the scores in various patients. 
Finally, this definition is based on a draft definition that 
has been developed using fictitious clinical cases and an 
international PICU physician opinion survey. The risk of 
opinion bias has been adjusted with the modification of 
this definition and the constitution of the septic shock 
scores tailored to an actual patient population. This def-
inition is very coherent in real life, shown by the excel-
lent discriminative power of both scores in the validation 
cohort. In regard of these limitations, a prospective study 
is warranted for refinement and external validation of 
this definition.
Conclusion
In conclusion, we have defined refractory septic shock in 
children as the association of high blood lactate with high 
vaso-inotrope doses associated with myocardial dysfunc-
tion. This definition is based on two septic shock scores 
showing excellent discriminative power in a multicen-
tre validation population. The RSS Computed Score is a 
powerful and potentially useful tool to compare patients 
in future interventional randomized multicenter studies 
on septic shock. The RSS Bedside Score is easy to calcu-
late and may assist in determining patients who would be 
suitable for inclusion in clinical trials of rescue therapies.
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